Atlas Trials

Lexicon Pharmaceuticals

61 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lexicon Pharmaceuticals

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy (NCT06481891)Lexicon Pharmaceuticals2024-09-24
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) (NCT06203002)Lexicon Pharmaceuticals2023-11-29
Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia (NCT04662281)Lexicon Pharmaceuticals2020-12-10
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain (NCT04455633)Lexicon Pharmaceuticals2020-09-03
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) (NCT03521934)Lexicon Pharmaceuticals2018-06-15
Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (NCT03386344)Lexicon Pharmaceuticals2018-02-19
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk (NCT03315143)Lexicon Pharmaceuticals2017-12-19
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure (NCT03292653)Lexicon Pharmaceuticals2017-12-04
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy (NCT03332771)Lexicon Pharmaceuticals2017-12-01
Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment (NCT03423446)Lexicon Pharmaceuticals2017-11-28
Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin (NCT03351478)Lexicon Pharmaceuticals2017-11-27
A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects (NCT03302845)Lexicon Pharmaceuticals2017-09-21
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents (NCT03285594)Lexicon Pharmaceuticals2017-09-15

Track Lexicon Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.